Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
Curious About Medically Supervised Weight Loss
doi: 10.1080/09546634.2019.1708853
If youve started semaglutide, you may have noticed changes beyond weight loss, including how well you sleep
Comprehensive Meal Ideas: Covers light breakfasts, satisfying lunches, quick dinners, and smart snacks
While traditional GLP-1 agonists focus on a single pathway, retatrutide functions as a triple agonist, integrating signals from three distinct metabolic receptors: GLP-1: Associated with slowed gastric emptying, appetite modulation, and glucose-dependent insulin secretion